The oral iron chelator deferasirox inhibits NF‐κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|168|4|576-582

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.4, 2015-02, pp. : 576-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Iron Chelator Deferasirox in the Treatment of Secondary Hemochromatosis following Bone Marrow Transplantation in a Patient with Severe Aplastic Anemia

By  

Acta Haematologica, Vol. 125, Iss. 4, 2011-01 ,pp. : 219-221

Karger

Access to resources Recommend Favorite

NF-ΚB Decoy Oligodeoxynucleotides Inhibits Kupffer Cell Activation

By  

Current Signal Transduction Therapy, Vol. 10, Iss. 1, 2015-01 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Deferasirox: a novel, once-daily oral iron chelator

By Cappellini Maria Domenica  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 453-460

Future Medicine

Access to resources Recommend Favorite

Diphenyleneiodonium inhibits NF-κB activation and iNOS expression induced by IL-1β: involvement of reactive oxygen species

By Ferreira Mendes A.   Pato Carvalho A.   Margarida Caramona M.   Celeste Lopes M.  

Mediators of Inflammation, Vol. 10, Iss. 4, 2001-08 ,pp. : 209-215

Informa Healthcare

Access to resources Recommend Favorite

The Flavonoid 7,4′‐Dihydroxyflavone Inhibits MUC5AC Gene Expression, Production, and Secretion via Regulation of NF‐κB, STAT6, and HDAC2

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 6, 2015-06 ,pp. : 925-932

John Wiley & Sons Inc

Access to resources Recommend Favorite